[Prevention of arrhythmia as a cause of sudden death].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to K Wrabec.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
14 patients with chronic bronchitis were observed after from 1.5 to 8 years of regular treatment with corticosteroids of sustained action given intramuscularly. The patients were analysed from the standpoint of age, sex, duration of corticosteroid treatment, type and dose of the drugs, and smoking. In 9 of them accelerated development of osteoporosis was noted its appearance depended significantly only on age and sex.
Twenty-one patients with infectious endocarditis are reported. The diagnosis was based on finding of at least three clinical symptoms and signs, including systemic manifestations, cardiovascular signs such as the appearance of a new or changing symptoms of cardiac failure, episodes of embolism and abnormalities in laboratory investigations and features of valvular involvement by the inflammatory process, principal changing endocardium image was evidence of an active inflammatory process. The aetiological factors, diagnostic difficulties, therapeutic results and the usefulness of echocardiography in the diagnosis of infectious endocarditis are discussed.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Both oral and intravenous ipratropium bromide were assessed clinically, electrocardiographically and electrophysiologically in 15 patients with symptomatic bradycardia, aged between 32 and 79 years. Ipratropium bromide administered intravenously accelerated heart rate by more than 30% in the majority of patients. Electrophysiologically it normalized conduction time and sinus node response. Electrophysiological studies did not enable to foreseen the efficiency of oral form which may be useful in the treatment of symptomatic bradycardia in increased parasympathetic tone and both mild, and moderate sinus node insufficiency.